A BST RACT : Ba ckg ro und: Cortical neural correlates of ongoing cognitive decline in Parkinson's disease (PD) have been suggested; however, the role of subcortical structures in longitudinal change of cognitive dysfunction in PD has not been fully investigated. Here, we used automatic analysis to explore subcortical brain structures in patients with PD with mild cognitive impairment that converts into PD with dementia. Met ho ds: One hundred eighty-two patients with PD with mild cognitive impairment were classified as PD with mild cognitive impairment converters (n 5 74) or nonconverters (n 5 108), depending on whether they were subsequently diagnosed with dementia in PD. We used surface-based analysis to compare atrophic changes of subcortical brain structures between PD with mild cognitive impairment converters and nonconverters. Resu lts: PD with mild cognitive impairment converters had lower cognitive composite scores in the attention and frontal executive domains than did nonconverters.
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Subcortical shape analysis revealed that PD with mild cognitive impairment converters had smaller local shape volumes than did nonconverters in the bilateral thalamus, right caudate, and right hippocampus. Logistic regression analysis showed that local shape volumes in the bilateral thalamus and right caudate were significant independent predictors of PD with mild cognitive impairment converters. In the PD with mild cognitive impairment converter group, thalamic local shape volume was associated with semantic fluency and attentional composite score. C on clusi o ns: The present data suggest that the local shape volumes of deep subcortical structures, especially in the caudate and thalamus, may serve as important predictors of the development of dementia in patients with PD. Cognitive impairment is one of the most disabling nonmotor symptoms of Parkinson's disease (PD). A population-based, representative cohort study revealed that nearly 80% of patients with PD developed dementia. 1 Cognitive decline that is not normal for the age and educational level of the patient and is not associated with impaired functional activity is categorized as mild cognitive impairment in PD (PD-MCI). 2 The concept of PD-MCI has drawn a lot of attention, as it may predict patients who develop dementia or even help to prevent patients with PD from developing dementia by implementing potential neuroprotective therapies at this stage. 3 In terms of clinical factors that contribute to ongoing cognitive decline in patients with PD, Levodopa-nonresponsive axial motor symptoms 4 as well as cognitive performance encompassing posterior cortical domains of language, memory, or visuospatial function 5, 6 have been suggested to be closely associated with the development of dementia in PD (PDD). Pathologically, aside from Lewy body pathology, Alzheimer's disease (AD) pathology seems to play a crucial role in the development of PDD. 7 Regarding the neuroanatomical predictors of PDD, AD-like cortical atrophy, 8 atrophy in the frontostriatal area 9 or cholinergic structures, 10 and decreased neuronal metabolism in retrosplenial areas 11 have been suggested as neural correlates. Taken together, several studies have reported that the deep subcortical nucleus is also involved in cognitive dysfunction in PD, [12] [13] [14] despite having heterogeneous results depending on the image analysis technique. Currently, no biomarker has been validated as being able to predict the conversion to PDD, possibly because of the heterogeneity among PD-MCI patients. 15 In the present study, we explored subcortical brain structures in patients with PD-MCI who converted to PDD using a surface-based shape analysis procedure to further elucidate the role of subcortical structures in ongoing dementia in patients with PD.
Methods

Subjects
In this study, 182 patients with PD-MCI who underwent magnetic resonance imaging (MRI) and comprehensive neuropsychological studies at baseline and had at least 1 year of follow-up were recruited retrospectively from January 2007 to July 2016 at a university hospital. PD was diagnosed according to the clinical diagnostic criteria of the UK PD Society Brain Bank. 16 Part III of the Unified Parkinson Disease Rating Scale (UPDRS-motor), the Mini-Mental State Examination (MMSE), the Clinical Dementia Rating Scale (CDR), the Beck Depression Inventory (BDI), and the CrossCultural Smell Identification Test (CCSIT) were completed at the time of initial PD diagnosis. Levodopaequivalent dose was calculated with a previously described method. 17 We used the Seoul Neuropsychological Screening Battery to determine cognitive subsets in diagnosing PD-MCI and PDD. 18 The Seoul Neuropsychological Screening Battery includes the cognitive subsets of attention (forward and backward digit span, word and color Stroop), language and related functions (Korean version of the Boston Naming Test [K-BNT]), visuospatial function (Rey Complex Figure Test [RCFT], 6-point pentagon drawing test 19 , verbal memory (Seoul Verbal Learning Test; immediate recall, 20-minute delayed recall, and recognition), visual memory (RCFT; immediate recall, 20-minute delayed recall, and recognition), and frontal executive function (semantic and phonemic generative naming using the Controlled Oral Word Association Test, the 10-point Clock Drawing Test 20 . Age-, sex-, and education-specific norms for each cognitive test, based on 447 healthy subjects, were available. The scores were designated as abnormal if they were at least 1 standard deviation below the norms of matched healthy subjects. 18 A diagnosis of PD-MCI was made based on the criteria suggested by the Movement Disorder Society Task Force guidelines (level 1). 2 During a mean follow-up period of 38.2 months (range, 12-85 months), patients with PD-MCI were classified as PD-MCI converters (n 5 74, 40.7%) or nonconverters (n 5 108, 59.3%) according to a subsequent diagnosis of dementia. PD-MCI converters and nonconverters had no significant difference in mean follow-up period (36.8 and 38.9 months, respectively). PDD was diagnosed based on the Movement Disorder Society consensus criteria for diagnosing probable PDD. 21 Patients with focal brain lesions on conventional MRI or the presence of other neurodegenerative diseases that might account for dementia were excluded. Past medical comorbidities that could contribute to cognitive decline were also excluded. This study was approved by the Institutional Review Board at Yonsei University Severance Hospital, and written consent was obtained from all participants.
MRI Acquisition
All scans were acquired with a Philips 3.0 T scanner (Philips Intera; Philips Medical System, Best, The Netherlands) with a SENSE head coil (SENSE factor 5 2). A high-resolution, T1-weighted MRI volume data set was obtained from all subjects with a 3-dimensional T1-TFE sequence configured with the following acquisition parameters: axial acquisition with a 224 3 256 matrix; 256 3 256 reconstructed matrix with 182 slices; 220-mm field of view; 0.98 3 0.98 3 1.2 mm 3 voxels; TE, 4.6 milliseconds; TR, 9.6 milliseconds; flip angle, 8 8; and slice gap, 0 mm.
Shape Analysis of Subcortical Structures
A shape analysis of subcortical structures was performed by measuring the local shape volume of subcortical surface meshes. The shape analysis process consists of 4 steps: volume parcellation, surface extraction, registration, and local shape volume computation. In the first step, the anatomy of human subcortical structures was parceled from T1 images of each subject with the FreeSurfer software package (version 5.1.0; Athinoula A. Martinos Center at the Massachusetts General Hospital, Harvard Medical School; http://www.surfer.nmr.mgh.harvard.edu/). The parceled images were transformed to native anatomical space for surface extraction. In the second step, a surface mesh was extracted for each subject by deforming the template surface model. Specifically, subcortical shape atlas models 22 were used as a template surface, and the Laplacian-based surface 23, 24 was used to extract the subcortical surface of each subject. In the third step, the surface registration method developed by Cho et al 25 was used to establish the vertex correspondence of subcortical surface meshes across the sample. In the final step, the local shape volume of each vertex was measured by employing the method proposed by Shapira et al. 26 By definition, this measures the amount of local shape volume at each vertex, which therefore can be used to analyze surface-based atrophy of subcortical structures. Because each subcortical deep nucleus was composed of 2562 vertices, we compared corresponding vertices across individuals and between groups.
Statistical Analysis
The independent t test and v 2 test were used for continuous and categorical variables, respectively. Neuropsychological results were analyzed with analysis of covariance adjusted for age, sex, and years of education. Group differences in subcortical local shape volumes were assessed with analysis of covariance, whereas the predictive value of subcortical local shape volume for PDD conversion was evaluated using a logistic regression analysis after controlling for age, sex, years of education, total intracranial volume (ICV), and UPDRS-motor scores. Statistically significant vertices of each subcortical structure with odds ratios < 1 were expressed in logistic regression analysis. The Cox proportional hazards model was used to identify the cumulative time-dependent probability of PDD conversion. Proportional hazards assumption was tested using log-log plots. Vertices with significant hazard ratio (HR) < 1 were represented. In addition, we applied a more conservative cutoff (HR < 0.8) to identify the most potent predictors of PDD conversion among subcortical structures. False discovery rate correction (P < 0.05) was applied to address multiple comparisons. To investigate the correlation of subcortical local shape volume and neuropsychological findings in PD-MCI converters, a partial correlation coefficient adjusted for age, sex, years of education, and ICV was performed. A multiple-comparisons correction using the cluster-based statistics method was conducted in accordance with a previous report, 27 with the initial threshold of the correlation coefficients set to 0.30. Statistical analyses were performed with commercially available software (SPSS, version 23.0), and a 2-tailed P < 0.05 was considered statistically significant.
Results
Demographic Characteristics
The demographic characteristics of PD-MCI converters and nonconverters are summarized in Table 1 . PD-MCI converters and nonconverters had no significant differences in sex, years of education, duration of parkinsonism, duration of memory impairment, duration of follow-up, BDI score, CCSIT score, levodopaequivalent dose, or ICV. PD-MCI converters were significantly older than nonconverters (71.4 6 6.8 vs 69.2 6 6.5, P 5 0.028). PD-MCI converters had lower MMSE scores (25.3 6 2.9 vs 26.6 6 2.6, P 5 0.001) and higher CDR scores (0.5 6 0.2 vs 0.5 6 0.1, P 5 0.048) than did PD-MCI nonconverters. In addition, PD-MCI converters tended to have higher UPDRS-motor score than did nonconverters (25.2 6 13.3 vs 21.5 6 9.0, P 5 0.053), although the difference was not statistically significant.
Comparison of Cognitive Performance Between PD-MCI Converters and PD-MCI Nonconverters
Neuropsychological characteristics in PD-MCI converters and nonconverters are compared in Table 2 . 
After controlling for age, sex, and years of education and correction for multiple comparisons, PD-MCI converters performed significantly worse on the color Stroop test (P 5 0.015), verbal immediate memory (P 5 0.040), visual delayed memory (P 5 0.033), semantic generative naming (P 5 0.001), and phonemic generative naming (P 5 0.039) than did nonconverters. PD-MCI converters had lower cognitive performance scores in the attention and frontal executive domains than did nonconverters. The composite scores in other domains did not differ significantly between groups.
Comparison of Subcortical Local Shape Volume Between PD-MCI Converters and PD-MCI Nonconverters
Subcortical local shape volume in PD-MCI converters and nonconverters is compared in Figure 1 . In analysis of covariance adjusted for age, sex, years of education, and ICV, PD-MCI converters had smaller local shape volumes than did nonconverters in the bilateral putamen, bilateral thalamus, right caudate, and right hippocampus. The thalamus had the greatest difference in local shape volume between PD-MCI converters and nonconverters. When adjusting for UPDRS-motor scores, bilateral putamen did not show a significant local shape volume difference between groups. Local shape volume differences in the left caudate, bilateral pallidum, bilateral amygdala, and left hippocampus were not statistically significant.
Predictive Value of Subcortical Local Shape
Volume for the Development of PDD Logistic regression analysis after adjusting for age, sex, years of education, ICV, and UPDRS-motor scores showed that local shape volumes in the bilateral thalamus and right caudate were significant independent predictors of PD-MCI converters ( Fig. 2A) .
To assess the relationship between baseline subcortical local shape volume and time to onset of PDD, we applied Cox proportional hazards models. Univariate Cox analyses revealed that the age at diagnosis (P 5 0.001) predicted later conversion to PDD, and MMSE score (P 5 0.070) showed a trend toward PDD conversion. Multivariate Cox analyses including demographic factors (age at onset and MMSE) and each subcortical local shape volume showed that all subcortical deep structures have significant predictive value for the development of PDD (HR < 1, Supplementary Table S1 ). Using a strict cutoff value (HR < 0.8), multivariate Cox analyses showed that the most potent predictors of PDD conversion among subcortical structures were shape changes in the thalamus and caudate (Fig. 2B) . Group comparison with composite scores for cognitive domains.
C H U N G E T A L
Correlation of Subcortical Local Shape Volume and Neuropsychological Findings in PD-MCI Converters
For cognitive subdomains in which PD-MCI converters performed worse than nonconverters, we performed a correlation analysis between subcortical local shape volume and cognitive scores in PD-MCI converters. After the cluster-based correction, cognitive performance on semantic generative naming was positively correlated with local shape volume in the left thalamus (Fig. 3A) . In composite scores, the left thalamus local shape volume was significantly and positively associated with attentional performance (Fig. 3B) .
Discussion
The primary finding of the present study was that PD-MCI converters had smaller subcortical volumes in the bilateral thalamus, right caudate, and right hippocampus than did PD-MCI nonconverters. Logistic regression analysis showed that the thalamus and caudate local shape volumes were independent predictors of PD-MCI converters. In addition, a correlation analysis showed that the thalamic local shape volume was closely associated with semantic fluency and attentional composite score in PD-MCI converters. Taking into account that there were no significant differences in possible confounders, such as sex, duration of parkinsonism, and ICV, these data suggest that the volumes of deep subcortical structures, especially the caudate and thalamus, may serve as important predictors of the development of PDD.
Based on pathological 28, 29 and neuroimaging studies, 15 ample evidence indicates that cortical structures play an important role in cognitive impairment in PD. In addition, the frontostriatal circuit involves cognitive performance in PD, and thus, dysfunction in dopaminergic frontostriatal circuits contributes to cognitive dysfunction, particularly to executive cognitive dysfunction. 6, 30 The striatum can be subdivided into 3 distinct functional sectors: the associative striatum, sensorimotor striatum, and limbic striatum. 31 The associative striatum consists of the caudate and anterior putamen and receives projections from dopaminergic neurons in the medial substantia nigra. 32, 33 The associative striatum is reciprocally connected with various association cortices in the frontal, temporal, and parietal lobes, thus playing an important role in cognitive performance. 34 A smaller volume in the caudate nucleus of PD-MCI converters relative to PD-MCI nonconverters is in line with a previous study using a voxel-based morphometric analysis. 35 The present study also demonstrated that PD-MCI converters had a smaller putamen volume, especially in the anterior portion, than did PD-MCI nonconverters. However, this difference was not statistically significant after
Comparison of subcortical local shape volumes between Parkinson's disease with mild cognitive impairment converters and nonconverters. Nongray color represents local shape volume differences between groups after false discovery rate threshold, with red indicating higher statistical significance. The area of decreased local shape volume in Parkinson's disease with mild cognitive impairment converters involves the bilateral thalamus, right caudate, and right hippocampus, with more extensive changes in the thalamus. [Color figure can be viewed at wileyonlinelibrary.com]
adjusting UPDRS motor scores, which suggests that putaminal atrophy may be primarily associated with parkinsonian motor symptoms. According to pathological studies, striatal pathology has been suggested to play an important role in cognitive dysfunction in PD. Tsuboi et al 36 reported that a-synuclein pathology in the striatum was greater in patients with PDD compared with nondemented patients with PD. Kalaitzakis et al 37 demonstrated that b-amyloid deposition in the striatum was higher in patients with PDD. Therefore, striatal atrophy might act as a possible neuroanatomical predictor for ongoing cognitive decline in patients with PD-MCI. The present study demonstrated that PD-MCI converters had reduced local shape volume in the thalamus compared with PD-MCI nonconverters. Moreover, the thalamic local shape volume was closely coupled with semantic fluency and attention in PD-MCI converters. In addition to sensory and motor functions, the thalamus plays an important role in cognitive function, involving executive function, language, memory, attention, and visuospatial abilities. 38 In patients with PD, the role of the thalamus in cognitive performance has also been widely suggested. Janzen et al 39 reported that thalamic atrophy was closely associated with visual hallucination in patients with PD as a result of denervation of cholinergic input from the pedunculopontine nucleus. Neuroimaging studies using a cholinergic ligand illustrated that the thalamus was the region of greatest postsynaptic cholinergic dysfunction in patients with PD. 40 The largest reduction of presynaptic cholinergic activity was in the thalamus of patients with PDD. 41 Recently, we provided evidence that thalamic volume is a major contributor to the development of freezing of gait in nondemented PD patients. 42 Visual hallucinations and freezing of gait are well-known clinical risk factors for future cognitive decline in patients with PD. 4, 43 Regarding the pathologic substrate of the 
thalamus, R€ ub et al 44 reported that the thalamus is a target of extranigral Lewy body pathology that is absent in the thalamus of healthy controls. Halliday and colleagues 45 provided pathological evidence that asynuclein deposition and neuronal degeneration in the thalamus are common and that thalamic pathologies appear to affect cognitive performance in patients with PD. In addition, PD-related pathology in the thalamus is largely concentrated in the limbic thalamus (eg, anterior thalamic nuclei, lateral dorsal nucleus, medial dorsal nucleus). 44 The limbic thalamus is closely connected to hippocampal formation and retrosplenial cortex and thus has a key role in cognitive function, especially memory and attention. 38 Several longitudinal neurocognitive studies showed that PD-MCI converters exhibited more deficits in the attentional domain (especially color Stroop) 46 and semantic fluency task. 47 One crosssectional study demonstrated that lower scores on attentional domain and semantic fluency were associated with a transition from PD-MCI to PDD. 48 In addition, semantic fluency has been identified as a key predictor of PDD in a longitudinal cohort study 49 and included in predictive models of outcome in PD. 50 Likewise, PD-MCI converters in this study showed a significant relationship between the substantial portion of the limbic thalamus and semantic fluency and attention, suggesting an important role of thalamic atrophy in the development of PDD. Collectively, the present study indicates that the thalamus has an important role in the development of dementia in patients with PD.
The role of the hippocampus in the development of cognitive impairment in PD is not conclusive. Hippocampal atrophy is less prominent in patients with PDD than in those with Alzheimer's disease or dementia with Lewy bodies. However, a previous volumetric MRI study demonstrated that hippocampal atrophy is closely associated with ongoing cognitive decline in patients with PD. 51 In addition, the degree of longitudinal atrophy in the hippocampus is more severe in patients with PD-MCI than in cognitively normal PD or healthy subjects. 14, 52 Neuropathological studies also reported that atrophy and Lewy neuritis in the CA2 region of the hippocampus are related to the severity of cognitive dysfunction in PD by interrupting links to the CA1 region. 53, 54 Neuropsychological data from the present study demonstrate that PD-MCI converters have worse visual memory than do PD-MCI nonconverters, supporting the role of hippocampal atrophy in PD-MCI converters. Thus, morphological changes in the hippocampus may precede dementia and can be a predictive factor for PDD. However, given that the area of hippocampal atrophy was smaller than striatothalamic atrophy or had no predictive role in logistic regression analysis, the role of the hippocampus in predicting PDD conversion appears to be smaller than that of the striatum.
The subcortical structures responsible for PDD conversion were lateralized in the present study. It appears that there are neuroanatomical asymmetries in patients with PD, which may reflect cognitive dysfunction. Tomer et al 55 demonstrated that damage to the right-hemisphere dopamine systems plays a disproportionately greater role in PD-related cognitive decline than the presumably comparable lefthemisphere dopamine depletion. Katzen et al 56 also suggested that damage to the right basal ganglia may have greater negative impact on cognition in PD patients. Further neuroimaging studies are required to confirm the independent role of the asymmetric subcortical structure in PD-related cognitive dysfunction, as this is predominantly influenced by asymmetric motor deficits. 57 There are several strengths to the present study. The comparisons between a large number of PD-MCI converters and nonconverters reduced patient-sampling bias. In addition, measuring local shape volume, particularly compared with voxel-based morphometry, which can only analyze whole structure volumes, provided a more delicate methodology and reflected even slight variations in subcortical structures. However, this study had several limitations. First, the time between baseline and follow-up neuropsychological testing varied among subjects. Nevertheless, the mean follow-up period was comparable among groups, which should minimize the effect of time. Second, the PD-MCI diagnosis did not meet the level 2 category of the Movement Disorder Society Task Force guidelines, 2 as our evaluation of language and related function was limited to 1 typical test (ie, K-BNT). Therefore, some patients with PD-MCI in this study may have been false-positives. Finally, we only assessed initial MRI data, so the longitudinal changes in subcortical structures could not be evaluated.
In summary, our data demonstrate that atrophy in the caudate and thalamus is closely associated with ongoing cognitive decline in patients with PD-MCI, emphasizing the role of subcortical structures as viable PDD predictors. A prospective longitudinal follow-up study could be instrumental for confirming the subcortical deep nucleus as a valuable factor of further cognitive impairment in patients with PD.
